Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Safety of Abediterol and AZD7594 in Healthy Volunteers
NCT02967159Phase 1Completed
- Sponsor
- AstraZeneca
- Start
- Nov 2016
- Primary completion
- Apr 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of velsecorat and abediterol in chronic obstructive pulmonary disease (COPD) and asthma (4 arms), sponsored by AstraZeneca. Primary endpoints: Area under the plasma concentration time curve, Maximum observed plasma concentration and 4 more. Started Nov 2016; status: completed.
02
Drugs
velsecoratabediterol
03
Conditions
chronic obstructive pulmonary disease (COPD)asthma
Beyond the preview
Go deeper on NCT02967159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02967159.